Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-035184

Options or other derivatives

  • EVP & CFO acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foster Jonathan P. EVP & CFO 2025-11-12 Grant or award · Stock option (right to buy) +600,000 1,617,695 D: show line 1 in the form
Foster Jonathan P. EVP & CFO 2025-11-12 Grant or award · Performance Based Restricted Stock Units +400,000 2,017,695 D: show line 2 in the form
Loading xslF345X05/rdgdoc.xml…